Gabriele Ricci Insider Profile
4 Followers
Gabriele Ricci, Chief Technology Officer at Takeda Pharmaceutical Co, holds 85.83K shares in Takeda Pharmaceutical Co (Ticker: TKPHF). Most recently, Gabriele Ricci Sold 12,544 shares of Takeda Pharmaceutical Co on Aug 12, 2026 for an estimated value of $429.00K.
Gabriele Ricci Takeda Pharmaceutical Co (TKPHF)Chief Technology Officer
Takeda Pharmaceutical Co (TKPHF)
Chief Technology Officer
Ranked #76,109 out of 109,349 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Gabriele Ricci's holdings
Insider Roles
Chief Technology Officer
Roles that Gabriele Ricci holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 11, 2023 - Jul 11, 2024
Return:+11.20%
The most profitable trade made by Gabriele Ricci
Gabriele Ricci's Trading History
List of latest transactions for each holding click on a transaction to see Gabriele Ricci's performance on stock
You May Also Like
Gabriele Ricci insider profile FAQ
What is the percentage of profitable transactions made by Gabriele Ricci?
The percentage of profitable transactions made by Gabriele Ricci is 20%.
What is the average return per transaction made by Gabriele Ricci?
The average return per transaction made by Gabriele Ricci is -12.10%.
What stocks does Gabriele Ricci hold?
Gabriele Ricci holds: TKPHF stocks.
What was Gabriele Ricci’s latest transaction?
Gabriele Ricci latest transaction was an Informative Sell of $429.00K.
What was Gabriele Ricci's most profitable transaction?
Gabriele Ricci’s most profitable transaction was an Informative Sell of TKPHF stock on July 11, 2023. The return on the trade was 11.20%.
What is Gabriele Ricci's role in Takeda Pharmaceutical Co?
Gabriele Ricci's role in Takeda Pharmaceutical Co is Chief Technology Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.